Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$936K Buy
+19,265
New +$1.12M 0.03% 226
2024
Q1
Sell
-7,291
Closed -$460K 496
2023
Q4
$460K Buy
+7,291
New +$423K 0.02% 340
2023
Q3
Sell
-4,109
Closed -$429K 480
2023
Q2
$429K Buy
+4,109
New +$462K 0.06% 290
2021
Q2
Sell
-3,271
Closed -$362K 509
2021
Q1
$362K Buy
+3,271
New +$362K 0.03% 227
2019
Q3
Sell
-3,592
Closed -$298K 443
2019
Q2
$298K Buy
+3,592
New +$282K 0.04% 285
2018
Q1
Sell
-10,461
Closed -$859K 363
2017
Q4
$859K Sell
10,461
-36,005
-77% -$2.89M 0.04% 224
2017
Q3
$3.6M Buy
+46,466
New +$3.34M 0.13% 151
2017
Q2
Sell
-34,590
Closed -$2.09M 501
2017
Q1
$2.09M Buy
+34,590
New +$1.79M 0.01% 172

Other funds holding FMC

Caxton Associates (New York)'s FMC Position: Q4 2024 in Review

Caxton Associates (New York) opened a new position in FMC (FMC) in Q4 2024: 19,265 shares worth $936K. The stake represents 0.03% of the portfolio and ranks #226 among its holdings. This is a return to the name: Caxton Associates (New York) previously reported a position in FMC as recently as Q4 2023.

Caxton Associates (New York) first reported a position in FMC in Q1 2017 and has held it in 8 quarters since. The position peaked at $3.6M in Q3 2017. 595 funds tracked by Wall St. Rank hold FMC as of Q4 2024.

  • Caxton Associates (New York) held 19,265 shares of FMC worth $936K as of Q4 2024.
  • FMC was a new Caxton Associates (New York) position in Q4 2024.
  • FMC made up 0.03% of Caxton Associates (New York)'s portfolio in Q4 2024, its #226 holding.
  • Caxton Associates (New York) first reported a position in FMC in Q1 2017 and has held it in 8 quarters since.
  • Caxton Associates (New York)'s FMC position peaked at $3.6M in Q3 2017.
  • 595 funds tracked by Wall St. Rank held FMC as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.